Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
Open-market buys, last 90 days
$6,396,312
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$6.3M 10% owner 4 filings
  2. Doogan Declan +$102K Director 1 filing
  3. Giordano Christopher Thomas +$20K CEO 1 filing
  4. STAAB THOMAS R II +$11K Chief Financial Officer 1 filing

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-01 PROEHL GERALD T Director Grant or award · Stock Option (right to buy) +500 500
2020-05-01 Mitchum James P. Director Grant or award · Stock Option (right to buy) +500 500
2020-05-01 BLANCK RONALD R Director Grant or award · Stock Option (right to buy) +500 500
2020-03-01 Jebsen Michael B CFO Grant or award · Stock Option (right to buy) +75,000 75,000
2020-03-01 DiTonno Anthony A CEO Grant or award · Stock Option (right to buy) +75,000 75,000
2019-05-01 RALLIS CHRIS A Director Grant or award · Stock Option (right to buy) +500 500
2018-07-31 Jebsen Michael B CFO Returned to the company +5,720 $6.25 $36K 34,680
2018-06-01 DiTonno Anthony A CEO Grant or award · Stock option (right to buy) +50,000 50,000
2018-05-01 Mitchum James P. Director Grant or award · Stock Option (right to buy) +500 500
2018-05-01 DiTonno Anthony A Director Grant or award · Stock Option (right to buy) +500 500
2018-05-01 BLANCK RONALD R Director Grant or award · Stock Option (right to buy) +500 500
2018-05-01 PROEHL GERALD T Director Grant or award · Stock Option (right to buy) +500 500
2018-03-30 Jebsen Michael B CFO Returned to the company +6,425 $5.42 $35K 12,310
2017-12-29 Jebsen Michael B CFO Returned to the company +98 $0.43 $42 68,264
2017-12-18 BLANCK RONALD R Director Purchase +6,475 $0.46 $3K 13,624
2017-12-18 BLANCK RONALD R Director Purchase +6,475 $0.45 $3K 20,099
2017-11-14 BLANCK RONALD R Director Sale −12,950 $0.39 $5K 7,149
2017-07-31 Jebsen Michael B CFO Returned to the company +54 $0.65 $35 68,146
2017-04-15 Jebsen Michael B CFO Returned to the company +56 $0.54 $30 68,200
2017-04-03 Jebsen Michael B Interim CEO, President and CFO Grant or award · Stock Option (right to buy) +200,000 200,000

Page 8 of 9 · 172 trades